A system or rotary atherectomy (Rotablator) was evaluated on coronary stenoses in Man. This device consists of catheter presenting an abrasive olive-shaped knob at one end, and sliding over a central metallic guide, rotating at more than 150,000 tpm. This drill liquifies the atheroma in small microparticles able to cross the microcirculation. The atherectomy surface is perfectly smooth and the risk of thrombosis is minimum. The atherectomy technique is quite simple, similar to PTCA, the balloon being replaced by a drill with a diameter ranging from 1.25 to 2 mm. 48 stenoses in 45 patients were treated with this technique. Twice, the Rotablator's guide was unable to cross the stenosis. In other cases, the stenosis was decreased, in an average, by 75 p. cent (SD 24%) to 43 p. cent (SD 20%) (p less than 0.001). The segment treated is characterized by smooth, linear edges without parictal minithrombi. Complications are most unusual (no deaths, no extended infarction, no emergency bypass related an early reobstruction). The coronary artery may react to the passage of the Rotablator by a spasm; this coronary spasm disappears (sometimes in a few hours) under nitrates derivatives perfusion. The middle term results are very encouraging; in fact, in 19 patients who underwent a control coronary angiography 3 months later, 3 (15%) presented a stenosis. In conclusion, rotary angioplasty is an easy, effective and harmless technique. The exact percentage of re-stenosis remains to be specified in larger series.
Download full-text PDF |
Source |
---|
Rev Port Cardiol
January 2025
Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal; Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal.
Introduction And Objectives: Rotational atherectomy (RA) is widely used for the management of calcified coronary stenoses. However, there is limited data on its use, trends, and outcomes. We sought to report our twelve-year experience with RA and explore the trends and outcomes of percutaneous coronary intervention (PCI) with this device.
View Article and Find Full Text PDFKardiol Pol
January 2025
Clinical Department of Interventional Cardiology, Medical University of Lublin, Lublin, Poland.
J Am Heart Assoc
January 2025
Monash Heart Victorian Heart Hospital, Monash Health Melbourne Australia.
Background: Preprocedural fasting is widely used before percutaneous coronary intervention (PCI). However, the incidence of procedural intubation during PCI is unknown. This study aims to identify the incidence and predictors for procedural intubation during PCI.
View Article and Find Full Text PDFCardiol Rev
January 2025
Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York City, NY.
Coronary artery calcification is an impediment to percutaneous coronary interventions by obstructing the device pathway or stent deployment. To facilitate percutaneous coronary intervention in such complex lesions, high-pressure balloon dilations, atherectomy procedures, and specialty balloons are used but they all come with considerable limitations and periprocedural complications like dissection and perforation. To surpass these disadvantages, intravascular lithotripsy was introduced which acts by delivering high-pressure pulsatile sonic waves circumferentially thereby destroying the calcium deposits.
View Article and Find Full Text PDFCardiovasc Revasc Med
January 2025
Department of Pharmacology, Federal University of the São Francisco Valley, Petrolina, PE, Brazil. Electronic address:
This letter to the editor provides a critical and constructive analysis of the article "Intravascular Lithotripsy Compared with Rotational Atherectomy for Calcified Coronary Lesions: A Meta-analysis of Outcomes", highlighting key methodological limitations and the exclusion of relevant contemporary studies. It emphasizes the clinical importance of addressing severely calcified coronary lesions, a significant challenge in interventional cardiology, and advocates for future research to prioritize randomized clinical trials, subgroup analyses, and cost-effectiveness evaluations to improve the applicability of findings across healthcare settings. By promoting dialogue within the scientific community and encouraging the integration of evolving data, the letter aims to refine clinical strategies and align them with evidence-based public health approaches, particularly in resource-limited environments.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!